Samuel Rahbar | Academic Influence

Samuel Rahbar's AcademicInfluence.com Rankings

Samuel Rahbar

Biology

#245

World Rank

#445

Historical Rank

Biotechnology

#35

World Rank

#36

Historical Rank

Molecular Biology

#2579

World Rank

#2620

Historical Rank

biology Degrees

Download Badge

Biology

Samuel Rahbar's Degrees

Bachelors Biology University of Tehran
Masters Biotechnology University of Tehran
PhD Molecular Biology University of Tehran

Similar Degrees You Can Earn

Best Online Bachelor's in Biology 2025

Why Is Samuel Rahbar Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Samuel Rahbar was an Iranian scientist who discovered the linkage between diabetes and HbA1C, a form of hemoglobin used primarily to identify plasma glucose concentration over time. Rahbar was born into a Jewish family in the Iranian city of Hamedan in 1929. He obtained his MD degree from the University of Tehran in 1953 and a PhD degree in immunology from the same university in 1963.

(See a Problem?)

Samuel Rahbar's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

An abnormal hemoglobin in red cells of diabetics. (1968) (385)
Novel inhibitors of advanced glycation endproducts. (2003) (364)
Studies of an unusual hemoglobin in patients with diabetes mellitus. (1969) (356)
Evidence that pioglitazone, metformin and pentoxifylline are inhibitors of glycation. (2000) (149)
The Discovery of Glycated Hemoglobin: A Major Event in the Study of Nonenzymatic Chemistry in Biological Systems (2005) (117)
Novel inhibitors of advanced glycation endproducts (part II). (2000) (103)
Two Haemoglobins Q, α74 (EF3) and α75 (EF4) Aspartic Acid→Histidine (1970) (86)
Anti-Inflammatory Effects of the Advanced Glycation End Product Inhibitor LR-90 in Human Monocytes (2007) (76)
Novel inhibitors of glycation and AGE formation (2007) (70)
LR-90 prevents methylglyoxal-induced oxidative stress and apoptosis in human endothelial cells (2014) (53)
A new advanced glycation inhibitor, LR-90, prevents experimental diabetic retinopathy in rats (2008) (49)
Advanced glycation end products of DNA: quantification of N2-(1-Carboxyethyl)-2'-deoxyguanosine in biological samples by liquid chromatography electrospray ionization tandem mass spectrometry. (2008) (48)
Abnormal haemoglobins in Iran. Observation of a new variant--haemoglobin J Iran (alpha-2-beta-2 77 His--Asp). (1967) (44)
Haemoglobin D Iran: β222 Glutamic Acid→Glutamine (B4) (1973) (42)
Molecular analyses of beta-thalassemia in Iran. (1995) (37)
Novel inhibitors of advanced glycation endproducts. (1999) (36)
Small‑molecule COH-SR4 inhibits adipocyte differentiation via AMPK activation. (2013) (35)
LR16, a compound with potent effects on the oxygen affinity of hemoglobin, on blood cholesterol, and on low density lipoprotein. (1988) (33)
Reverse phase high-performance liquid chromatography and secondary ion mass spectrometry. A strategy for identification of ten human hemoglobin variants. (1986) (32)
Rapid HPLC techniques for globin chain synthesis studies. (1989) (28)
Discrimination among the transcripts of the allelic human β-globin genes βA, βS and βC using oligodeoxynucleotide hybridization probes (1986) (28)
COH-SR4 Reduces Body Weight, Improves Glycemic Control and Prevents Hepatic Steatosis in High Fat Diet-Induced Obese Mice (2013) (26)
Prevention of early renal disease, dyslipidaemia and lipid peroxidation in STZ‐diabetic rats by LR‐9 and LR‐74, novel AGE inhibitors (2005) (24)
A new rapid method to detect inhibition of Amadori product generated by δ-gluconolactone (1999) (23)
Novel dichlorophenyl urea compounds inhibit proliferation of human leukemia HL-60 cells by inducing cell cycle arrest, differentiation and apoptosis (2012) (22)
A silent hemoglobin variant detected by HPLC: hemoglobin City of Hope beta 69 (E13) Gly----Ser. (1984) (20)
Hemoglobin North Chicago (beta 36 [C2] proline----serine): a new high affinity hemoglobin. (1985) (18)
Haemoglobin L Persian Gulf: α57 (E6) Glycine → Arginine (1969) (16)
1,3-Bis(3,5-dichlorophenyl) urea compound 'COH-SR4' inhibits proliferation and activates apoptosis in melanoma. (2012) (15)
Effects of a new advanced glycation inhibitor, LR‐90, on mitigating arterial stiffening and improving arterial elasticity and compliance in a diabetic rat model: aortic impedance analysis (2014) (14)
Hemoglobin H disease in two Iranian families. (1968) (14)
Hemoglobin Hammersmith (beta 42 (CD1) Phe replaced by Ser) associated with severe hemolytic anemia. (1981) (14)
Haemoglobin Hamadan: α2A β2 56 (D7) glycine → arginine (1975) (14)
Abnormal haemoglobins in Iran. Observation of a new variant haemoglobin J. Iran (α2 β2 77 His -> Asp). (1967) (14)
Hemoglobin Great Lakes (beta 68 [E12] leucine replaced by histidine): a new high-affinity hemoglobin (1981) (13)
Renoprotective and Lipid‐Lowering Effects of LR Compounds, Novel Advanced Glycation End Product Inhibitors, in Streptozotocin‐Induced Diabetic Rats (2005) (13)
Association of HB Hope [β 136(H14)GLY→ASP] and α-THALASSEMIA-2 (3.7 KB Deletion) Causing Severe Microcytic Anemia (1992) (12)
Association of hemoglobin H disease with Hb J-Iran (beta 77 His----Asp): impact on subunit assembly. (1987) (12)
Novel compound 1,3-bis (3,5-dichlorophenyl) urea inhibits lung cancer progression. (2013) (11)
HB Watts [α74(EF3) OR α75(EF4)ASP→0]: A Shortened α Chain Variant Due to the Deletion of Three Nucleotides in Exon 2 of the α2-Globin Gene (1997) (11)
Glycosylated minor C, D, and E hemoglobins. (1981) (11)
Hemoglobin Lepore Boston in two Iranian families. (1974) (10)
Hemoglobin Hammersmith as the Cause of Severe Hemolytic Anemia in a Chinese Girl (1986) (9)
Haemoglobin Daneshgah-Tehran α2 72 (EF1) Histidine→Arginine βA2 (1973) (9)
Indirect allosteric effects of a neutral mutation. Structure of deoxyhaemoglobin north Chicago (ProC2(36)beta----Ser). (1988) (9)
Haemoglobin Arya: α247 (CD5), aspartic acid → asparagine (1975) (8)
Haemoglobin D Iran: 2 22 glutamic acid leads to glutamine (B4). (1973) (7)
Two haemoglobins Q, alpha-74 (EF3) and alpha-75 (EF4) aspartic acid to histidine. (1970) (7)
Haemoglobin Avicenna (β47 (CD6) Asp → Ala). A new abnormal haemoglobin (1979) (7)
Two new haemoglobins: haemoglobin Perspolis [a 64 (E13) AspåTyr] and haemoglobin J-Kurosh [a 19 (AB) AlaåAsp] (1976) (7)
A new rapid method to detect inhibition of Amadori product generated by delta-gluconolactone. (1999) (6)
Hemoglobin J Paris (α12 Alanine→Aspartic Acid) in Two Iranian Families (1972) (6)
Further evidence for a post-translational phenomenon in the interaction of alpha-thalassemia with sickle cell trait. (1988) (6)
Hemoglobin: Structure, function, evolution, and pathology. (1983) (5)
Hemoglobin D Punjab in a Bulgarian Jewish family. (1969) (5)
A Novel Initiation Codon Mutation (ATG→ATT) in a β-Thalassemia Patient (1993) (5)
Iron overload in three generations of a family with hemoglobin Olympia. (1984) (5)
Microcytosis in Hodgkin disease associated with unbalanced globin chain synthesis (1986) (5)
A Second Case of Hemoglobin McKees Rocks (β145 Tyr → Term). A Variant with Premature Termination of the β-Chain (1983) (4)
Haemoglobin Daneshgah-Tehran alpha2 72 (EPI) histidine--arginine betaA2. (1973) (4)
A double heterozygous hemoglobin. Hemoglobin OIndonesia and hemoglobin DPunjab in an individual. (1975) (4)
A case of homozygous haemoglobin Lepore Boston in Iran. (1975) (4)
BETA THALASSEMIA ALLELS FOUND AMONG IRANIAN LIVING IN SOUTHERN CALIFORNIA (1990) (4)
Splice junction [IVS-II-1 (G-->C)] thalassemia; a new mutation detected in an Iranian patient. (1993) (3)
Mild sickle cell anemia associated with alpha globin mutant alpha Montgomery. (1989) (3)
A second case of Hb hanamaki [α2139 (HC1) LYS→GLU β2] in an american family with erythrocytosis (1994) (3)
Haemoglobin coventry (β 141 deleted) in iran (1978) (3)
Hemoglobin Setif (alpha94 (G1) Asp replaced by Tyr) in Iram. A report of 9 cases. (1977) (2)
Two new haemoglobins: haemoglobin Perspolis (alpha 64 (E13) Asp leads to Tyr) and haemoglobin J-Kurosh (alpha 19 (AB) Ala leads to Asp). (1976) (2)
Discrimination among the transcripts of the allelic human beta-globin genes beta A, beta S and beta C using oligodeoxynucleotide hybridization probes. (1986) (2)
Hemoglobin Osu-Christiansborg (beta52 (D3) Aspyield Asn) in an Iranian family. (1978) (2)
Haplotype analysis of the human beta-globin gene complex using multiple locus specific oligonucleotide probes. (1988) (2)
Association of Hb Hope [beta 136(H14)Gly----Asp] and alpha-thalassemia-2 (3.7 Kb deletion) causing severe microcytic anemia. (1992) (2)
Hemoglobinopathies in the Los Angeles area. (1983) (2)
Short Communications: Hemoglobin Osu-Christiansborg (β52 (D3) Asp→A5n) in an Iranian Family (2009) (2)
Haemoglobin L Persian Gulf: alpha-57 (E6) glycine leads to arginine. (1969) (1)
Two new haemoglobins: haemoglobin Perspolis [] and haemoglobin J-Kurosh [] (1976) (1)
A second case of hemoglobin McKees Rocks (beta 145 Tyr leads to Term). A variant with premature termination of the beta-chain. (1983) (1)
Haemoglobin Coventry (beta 141 deleted) in Iran. (1978) (1)
Haemoglobin M Boston in an Iranian family. (1977) (1)
A novel initiation codon mutation (ATG-->ATT) in a beta-thalassemia patient. (1993) (1)
Thalassemia: Recent advances in detection and treatment (1984) (1)
Protein Glycation and Diabetic Vascular Disease (1998) (1)
Haemoglobin hamadan: alpha-2A beta-2 56 (D7) glycine yields arginine. (1975) (1)
Abstract 2149: Novel compound 1, 3-bis (3, 5-dichlorophenyl) urea inhibits lung cancer progression (2014) (1)
Haemoglobin Arya: alpha 2-47 (CD5), aspartic acid yields asparagine. (1975) (1)
A New High-Affinity Hemoglobin (2017) (0)
LR-90 prevents methylglyoxal-induced oxidative stress and apoptosis in human endothelial cells (2014) (0)
Sickle cell disease. (1986) (0)
A novel intrachromosomal rearrangement in the beta-globin gene found in an African-American family. (1995) (0)
Haemoglobin O Indonesia (α116 Glutamic Acid → Lysine) in an Iranian Family (1973) (0)
Haemoglobin Avicenna (beta 47 (CD6) Asp replaced by Ala). A new abnormal haemoglobin. (1979) (0)
Abstract 5518: A novel 1,3-bis(3,5-dichlorophenyl) urea compound ‘COH-SR4’ for targeting melanoma. (2013) (0)
A Novel Intrachromosomal Rearrangement in the β-Globin Gene Fd in An African-American Family (1995) (0)
Hb Watts [alpha 74(EF3) or alpha 75(EF4)Asp-->0]: a shortened alpha chain variant due to the deletion of three nucleotides in exon 2 of the alpha 2-globin gene. (1997) (0)
New inhibitors of the formation of advanced glycosylation (2002) (0)
Hemoglobin Great Lakes (beta 68 [E12] leucine replaced by histidine): a new high-affinity hemoglobin. (1981) (0)
New inhibitors of the formation of ages (advanced glycation endproducts) (2004) (0)
Hemoglobin pasadena: Identification of the gene mutant by DNA analysis using synthetic DNA probes (1988) (0)
A second case of Hb Hanamaki [alpha 2 139(HC1)Lys->Glu beta 2] in an American family with erythrocytosis. (1994) (0)
Functional studies, anion-binding and effects of bezafibrate on three high affinity hemoglobin variants: Hb Olympia, Hb Great Lakes and Hb North Chicago. (1986) (0)

This paper list is powered by the following services:

Other Resources About Samuel Rahbar

en.wikipedia.org

What Schools Are Affiliated With Samuel Rahbar?

Samuel Rahbar is affiliated with the following schools: